Groundbreaking Discovery in Lupus Research Reveals Potential Cure
Groundbreaking discovery in lupus research reveals a molecular defect driving the pathologic immune response in systemic lupus erythematosus. Reversing this defect could potentially lead to a cure for the disease, offering hope for over 1.5 million affected individuals in the US. Current treatments for lupus fall short, but researchers have identified a specific cause that may mitigate side effects associated with existing therapies. By targeting key mediators, the team aims to suppress the autoimmune response imbalance in lupus patients, unveiling a novel pathway for potential future treatments.
Managing Lupus Symptoms
May is Lupus Awareness Month, highlighting the challenges faced by the 1.5 million Americans living with this chronic autoimmune disease. Learn about the importance of managing lupus symptoms, the impact of weight on symptom severity, and key strategies recommended by the Lupus Foundation of America for improved well-being.
Zhejiang University Makes History with CAR-T Therapy for Childhood-Onset SLE
Zhejiang University makes history by applying CAR-T therapy for childhood-onset systemic lupus erythematosus (SLE), showcasing promising results in addressing severe autoimmune disorders. The groundbreaking milestone in March 2024 marks the world’s first application of CAR-T therapy in a pediatric SLE case, offering new hope for personalized medicine and targeted therapies in the field of autoimmune disorders.